glp 1 drugs and blood clots A recent study suggests that GLP-1 medications, commonly prescribed for managing diabetes obesity, may also lower the risk of dangerous clots., The study’s lead author, Dr. Rushad Patell of GLP-1 attorney: complete guide to

During a median follow-up of 24 months in the intention-to-treat analysis, 3P-MACE occurred less frequently in the GLP-1RA cohort (HR versus BI 0.59

Its old school, but I have patients with type 1 and 2 diabetes who prefer vial and syringe to pen devices

While transitional assistance has stepped in for some, nearly 60% of written GLP-1 prescriptions remained unfilled in the first half of 2023

GLP-1 might be recommended for anyone who struggles with insulin resistance or prediabetes

They all activate GLP-1 receptors, and using two GLP-1 agonists simultaneously would increase side effect risk without proportional benefit

Start at a low dose regardless of your previous tirzepatide dose